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ABSTRACT 
 
The main activation route for the stress response is the hypothalamo-pituitary-
adrenal axis (HPA) and the sympatho-adrenomedullary system. The HPA axis is a 
neuroendocrine feedback loop mediated by an array of tissue specific hormones, 
receptors and neurotransmitters that regulate glucocorticoid (GC) release. GCs are 
steroidal hormones produced by the adrenal glands and are key players in a negative 
feedback loop controlling HPA activity. They influence the HPA axis through 
glucocorticoid receptors in the hypothalamus and pituitary and through both 
glucocorticoid (GR) and mineralcorticoid receptors (MR) that are co-localized in the 
hippocampus. Repeated or chronic stress exerts a negative influence on these HPA axis 
regulatory sites and contributes to potentially pathological conditions, especially during 
early development. For example, chronic stress promotes increased maternal adrenal 
gland secretion of glucocortiocoid, leading to abnormally high concentrations of GC in 
the fetal environment. The timing and maturation of the HPA axis relative to birth is 
highly species specific and is closely linked to landmarks in fetal development. In rats 
this development of the HPA axis takes place in utero and continues even shortly after 
birth. It is likely that the maternal endocrine environment will affect fetal development 
during this critical time point and may alter the overall set point for the expression of 
genes and their protein products that mediate fetal HPA axis function. Dexamethasone 
(DEX) is a synthetic glucocorticoid (sGC) and is a consensus treatment in preterm 
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pregnancies used to expedite fetal lung development. However it has been shown that 
DEX causes long term physiological and behavioral disorders in prenatally-exposed 
laboratory animals. Previous studies have also shown that it alters the MR: GR receptor 
ratio in the hippocampus. Taking into consideration corticosteroid regulation of serotonin 
receptors, especially 5HT1A receptors and their putative interaction with glucocorticoid 
receptors in the hippocampus, we hypothesized that prenatal DEX exposure would lead 
to changes in the expression and function of 5HT1A receptors in the hippocampus. We 
administered DEX to rat dams during the last trimester of gestation and investigated the 
changes in these receptors in the adult rat offspring. Radioligand receptor binding assays 
were used to study hippocampal 5HT1A receptor binding affinity and number. Our 
results demonstrate that hippocampal 5HT1A receptors are increased in the DEX animals 
compared with controls by 36%, with no change in binding affinity. The efficiency of 
ligand-induced receptor signal transduction via G-protein activation was also studied 
using [35S]GTPγS incorporation assay. Using this technique, we showed that there was no 
significant difference in the maximum ligand mediated stimulation (Emax) of 5HT1A 
receptors between control and dex exposed animals. However, the intracellular signalling 
efficiency of hippocampal 5HT1A receptors was diminished, since a significant increase 
in EC50 values was obtained with the dex exposed group showing a value 51% higher 
EC50 than controls. Taken together these data illustrate a considerable change in the 
5HT1A component of the serotonergic system following prenatal DEX exposure. 
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INTRODUCTION 
 
STRESS AND HPA AXIS 
Stress, originally defined by Hans Selye as a “non specific response of the body to 
a demand” may also be defined as any environmental change: either internal or external 
that disturbs the maintenance of homeostasis (Leonard, 2005). The stress response 
contributes to the maintenance of homeostasis (Sapolsky, 2003) which includes a series 
of physiological reactions such as endocrine activation and cardiovascular changes that 
normally do not cause any psychopathological problems. It is only when a prolonged and 
sustained stimulation exceeds the body capacity to maintain homeostasis that stress can 
have psychopathological sequelae (Chrousos & Gold, 1992). 
 When an organism is exposed to a stressor, several mechanisms are activated to 
restore homeostasis, most importantly, in the paraventricular nucleus of the 
hypothalamus. When this brain region is stimulated by stress, it releases corticotrophin 
releasing hormone (CRH) and its cosecretagogue arginine vasopressin (AVP) which 
induce the release of adrenocorticotropic hormone (ACTH) into the circulation (Chrousos 
& Gold, 1992). ACTH then stimulates adrenocortical cells in the rat adrenal glands to 
secrete corticosterone (CORT) into the blood (Palkovits , 1987). Thus corticosteroids are 
the main effectors of the HPA axis and their action mediated by corticosteroid receptors 
which include both MR and GR (Herman et al.,1989). Using autoradiographic and 
immunohistochemical techniques it has been shown that the hippocampus contains high 
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concentrations of both these receptors in comparison to other brain regions which contain 
only GR (Zhong & Ciaranello, 1995). The co-localization of these receptors in the 
hippocampus allows this region to play a key role in the regulation of negative feedback 
on HPA axis activity. This feedback system mediated by a delicate balance between MR 
and GR activation in the hippocampus keeps HPA activity in check and thus acts to 
mitigate psychopathological diseases.  
LIMBIC MODULATION OF HPA AXIS  
 Evidence clearly shows that the limbic system is a central modulator of the HPA 
axis (Jacobsen et al 1991 and Reul et al 1990) and that it is highly responsive to 
fluctuations in circulating corticosteroids (Matthews, 2002 ; McEwen, B.S, 1991 and 
Weinstock,  1997).  As previously stated, corticosteroid receptors are highly expressed in 
the limbic system particularly in the hippocampus (McEwen et al., 1968 and Sapolsky et 
al.,  1983) where GR and MR  are colocalized (Van Eekelen et al.,1988 and Van Haarst 
et al.,  1997). Corticosterone exerts its feedback regulation of the HPA axis through GR 
mediated inhibitory action at the level of the pituitary gland and the paraventricular 
nucleus (PVN) in the hypothalamus. At a higher integrative level, corticosterone exerts 
its effects on both hippocampal MR and GR depending on CORT concentration. Under 
basal conditions, hippocampal neurons exert an inhibition of HPA axis activity via a MR 
mediated mechanism. It follows that hippocampal GRs are activated by removing the 
tonic influence of ligand activated MRs which results in a stimulatory influence on HPA 
axis activity (De Kloet, 1991 and De Kloet et al., 1986).  
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 Serotonergic pathways originating in the midbrain raphe nuclei provide a 
widespread innervation of corticolimbic structures such as the hippocampus, amygdala, 
septum and frontal cortex (Abrams et al., 2005; Engin & Treit, 2007) and the activity in 
these regions is integrated with that of the HPA axis in the control of  glucocorticoid 
secretion and the stress response. Interestingly, animal studies have shown that 
corticosteroids can also alter several elements of serotonergic neurotransmission.  For 
example, removal of circulating corticosteroids by adrenlectomy results in anatomically 
specified decreases in the indices of serotonin metabolism while stressful procedures, 
which raise corticosteroid levels, produce corresponding increases in the turnover of 
serotonin (5HT) (Curzon et.al 1972 and Van Loon, G.R et.al 1981); however, 
corticosteroids may also act to  directly modulate serotonergic transmission via serotonin 
receptors (Watanabe et al., 1993). Further investigations confirmed the sensitivity of 
5HT1A receptors to circulating corticosteroid levels (De Kloet et al.1986) and indicate 
that specific hippocampal subfields are exquisitely sensitive to adrenal steroids. In 
addition, electrophysiological studies have shown a suppression of 5 HT induced 
hyperpolarization  within hippocampal Ammon’s horn 1 (CA1) pyramidal cells after 
brief application of steroids (Joel et al. 1991). These data indicate that there is a 
functional coupling between glucocorticoid and serotonergic function within the 
hippocampus. It is possible that the ascending serotonergic neurons originating in the 
midbrain raphe nuclei and projecting to postsynaptic 5HT receptors in the hippocampus 
may interact functionally at this site with glucocorticoid actions mediated by the balance 
between activated MR and GR.  Thus, the hippocampus represents a key anatomical 
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structure involved in the central control of limbic hypothalamo pituitary adrenal (LHPA) 
axis function and limbic circuitry. 
 In the brain 5HT is synthesized from the essential amino acid L-tryptophan 
exclusively in  serotonergic neurons located within the midbrain raphe nuclei and 
secretion of 5HT exerts a wide influence over many brain functions.  Seven different 
families of 5HT receptors with a total of 14 subtypes have been identified and six among 
the major seven are G-protein coupled heterotrimeric receptors (GPCRs) with seven 
transmembrane  α helices (Hoyer et al., 2002). Most serotonergic receptors are located 
postsynaptically, but 5HT1A and 5HT1B receptors are also located in the presynaptic 
neuron and function as autoreceptors (Boess et al., 1994).  5HT receptors are coupled to 
various effector systems mainly via G- proteins composed of the Gi /Go   type which act 
as inhibitors of adenylate cyclase (Raymond, et al., 1986). Stress activates the 
serotonergic neurons projecting to the hippocampus and  amygdala through cortical 
association areas and through ascending catecholaminergic neurons from the brain stem 
(Feldman et al. 1998 and Koob & Heinrichs, 1999). Interestingly, stress activation of the 
serotonergic system may stimulate both anxiogenic and anxiolytic pathways depending 
on the type of serotonin receptors stimulated.  Moreover, perturbations in serotonergic 
activity have been closely linked to the pathogenesis of anxiety and other psychaitric 
disorders  (Totterdell, 2006; Firk & Markus, 2007; Engin & Treit, 2007).  It has also been 
postulated that the serotonergic innervation of the amygdala and hippocampus mediates 
the anxiogenic effects of the transmitter by activating the 5HT2A receptors whereas 
activation of the 5HT1A receptors, which are highly expressed in the CA1 and CA3 
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regions of the hippocampus as well as in the dentate gyrus (DG) (Chalmers and Watson, 
1991; Pucadyil et al., 2005; Tokugawa et al., 2007), suppresses these anxiogenic effects 
(Graeff et al., 1993).  In support of this hypothesis 5HT1A knock out mice show 
increased anxiety and fear, while the chronic administration of the 5HT1A partial agonist, 
8-OH-DPAT, exerts anxiolytic effects both in rodents and in patients with generalised 
anxiety disorder (Ramboz et al., 1998). However studies conducted specifically on the 
autoreceptors of the presynaptic neuron and the postsynaptic population of  5HT1A 
receptors conclude that stimulation of presynaptic 5HT1A receptors induces anxiolytic 
effects through a reduction of 5HT release (Picazo et al., 1995; File et al., 1996; King et 
al., 1997; Millan et.al., 1999; Romaniuk et.al., 2001) whereas the administration of the 
5HT or the 5HT1A agonist 8-OH-DPAT into the amygdala  (Hodges et al.,1987; 
Gonzalez et al., 1996) and the dorsal hippocampus (Romaniuk et al., 2001) produces 
anxiogenic effects.  
 The stress response and its subsequent glucocorticoid output exert major effects 
on the expression of 5HT1A and 5HT2A receptors.  Moreover, the HPA axis mediates 
the stress response,  and its output  is under tonic inhibition by adrenal steroids in the 
hippocampus and elsewhere in the brain where mineralocorticoid receptors are expressed 
(Lopez et al., 1998). It has been demonstrated that the density of 5HT1A receptors 
decreases in response to chronic stress or the administration of glucocorticoid and 
increase after adrenalectomy.  In contrast,  5HT2A receptor expression is increased by 
chronic stress or  chronic glucocorticoid administration and decreased in response to 
adrenalectomy (Watanabe et al., 1993). In general,  glucocorticoid hormone increases 
8 
 
 
tryptophan hydroxylase activity, restores the decreased 5HT that occurs after 
adrenalectomy to more normal levels (Azmitia & McEwen, 1974), and regulates the 
synthesis and release of corticotropin-releasing factor (CRF) (Paull & Gibbs, 1983; 
Plotsky & Sawchenko, 1987; Akana et al., 1992). It has also been shown that 
glucocorticoid hormones, especially CORT, can selectively down regulate 5HT1A 
receptor mRNA expression in hippocampal areas, but not in the raphe nuclei (Neumaier 
et al., 2000), suggesting the the 5HT1A autoreceptors are not involved in this 
glucocorticoid action.  Moreover, evidence suggests that stress modifies the functionality 
of 5HT1A receptors. For instance, a variety of stimuli can induce desensitization of these 
receptors located in the dorsal raphe nuclei (Laaris et al., 1999;  Lanfumey et al.,1999), 
an effect mimicked by the injection of high doses of 5HT1A agonists (Kennett et al., 
1987; Beer et al., 1990; Seth et al., 1997). Overall, these findings suggest that 5HT1A 
receptors are influenced by glucocorticoid action and may mediate both glucocorticoid 
and serotonergic modulation of HPA axis activity.  
HPA AXIS DEVELOPMENT AND PRENATAL PROGRAMMING 
Cumulative evidence supports the claim that the HPA axis is highly susceptible to 
programming during development (Matthews, 2002; Meaney, 2001; Weinstock, 2001; 
Welberg and Seckl, 2001; Schneider et al., 2002; Sloboda et al., 2002). In the adult there 
is clear association between HPA function, glucocorticoids, and behavior, particularly in 
behavioral responses to stress (De Kloet et al., 1998). As a result, a number of research 
groups have investigated the influences of the perinatal environment on neonatal, juvenile 
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and adult behaviors (Matthews, 2002; Meaney 2001; Weinstock, 2001; Welberg & Seckl, 
2001; Schneider et al., 2002).  
The timing and maturation of the HPA axis relative to birth is highly species 
specific and is linked to landmarks of brain development (Dobbings & Sands, 1979). 
Growth factors, transcription factors and nutrients are known to affect brain development 
and steroids in particular have powerful brain programming properties (Matsumoto & 
Arai, 1997). The HPA axis is shown to have the greatest plasticity during the third 
trimester of gestation, a time when set points for basal expression of genes regulating the 
HPA axis are programmed according to genotype. If the fetal endocrine environment is 
abnormal, for example if the GC levels is in excess, genetic programming may be reset 
toward HPA axis hyperactivity.  
 Maternal stress during gestation may lead to a variety of behavioral, 
neuroendocrine, and neuroanatomical alterations in the offspring.  In the absence of direct 
neural connections between the developing fetus and the dam, maternal hormones have 
been hypothesized to mediate the effects of prenatal stress, particularly through 
alterations in the maternal HPA axis. The role of glucocorticoids as mediators of prenatal 
stress effects has been investigated by administering corticosterone (or synthetic 
analogues e.g DEX) to pregnant dams and results from these studies suggest that fetal 
glucocorticoid exposure mediates prenatal stress and programming of the offspring 
(Maccari  et al.,  2003; Welberg & Seckl, 2001).  Results from a few well designed 
human studies are concordant with decreased adaptation to novelty, altered attention and 
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increased emotionality (Huizink et al., 2004). Although the range of behavioral 
abnormalities is much more limited in animals than in humans, animal models allow for 
control of environmental factors and hypothesis testing based on manipulation of both the 
prenatal and postnatal enviroment (Weinstock, 2001). Animal models are therefore of 
great value in order to identify behavioral domains or physiological systems that are 
particularly vulnerable to prenatal stress, to investigate whether individual sensitivity 
plays a role, and to determine which physiological mechanisms mediate the effects of 
prenatal stress (Huizink et al., 2004). The adult offspring of rat dams subjected to 
stressors during gestation display increased anxiety-related behaviors, e.g., suppressed 
exploration of the open areas of elevated plus maze (Rimondini et al., 2003; Zimmerberg 
& Blaskey, 1998) and increased defensive withdrawal (Ward et al., 2000).  An important 
and more noticeable feature of prenatally stressed offspring is a hyperactive HPA axis 
with an elevated basal corticosterone level (Weinstock, M., 1997). However contrary to 
the aforementioned finding by Weinstock, there are reports that prenatal exposure to 
betamethasone decreases anxiety in developing rats which is attributed to the increase in 
the expression of neuropeptide Y in the hippocampus that is anxiolytic in nature (Velisek, 
2006)  
Glucocorticoids have become primary candidates for programming the fetal HPA 
axis in response to prenatal stress. They are essential for normal brain development and 
exert a wide spectrum of organizational effects. Under normal circumstances access of 
maternal endogenous glucocorticoid to the fetus is low for two reasons: (1) expression of 
11β hydroxysteroid dehydrogenase in the placenta reduces glucocorticoid-action by 
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(Burton & Wadell, 1999) converting cortisol and corticosterone to inactive products -
cortisone and 11- dehydrocorticosterone respectively and (2) corticosteroids are 
substantially complexed with proteins such as corticosteroid binding globulin (CBG) that 
render it incapable of penetrating the adult blood brain barrier or the feto-placental barrier 
(De Kloet et al., 1998 and Owen D. 2002).  
PRENATAL GLUCOCORTICOID THERAPY 
Extensive study by Liggins and Howie in the early 1970’s led to the widespread 
use of synthetic glucocorticoid (sGC) as a life saving treatment to prevent respiratory 
distress syndrome, by enhancing fetal lung development in those pregnancy cases in 
which preterm delivery is imminent (Liggins & Howie, 1972). Preterm delivery occurs in 
approximately 7- 10% of all births in North America and is responsible for about 75% of 
neonatal deaths (Effects of corticosteroid for fetal maturation and perinatal outcomes., 
NIH Consensus, 1995). Neonatal morbidity was also found to be very high in surviving 
preterm infants and complications such as respiratory distress syndrome, intraventricular 
hemorrhage and necrotizing enterocolitis are also common. An NIH consensus 
conference published a statement in 1994 indicating that one-time corticosteroid 
administration is safe and without side effects for prevention of respiratory distress 
syndrome in prematurely born neonates. This conclusion was based on a more positive 
outcome for the immediate perinatal health from numerous studies using this treatment 
(MacArthur et al.,1981; Schmand et al.,1990; Smolders-de Hass et al.,1990). The trend 
in clinical practice then progressed to a protocol involving repeat injections of synthetic 
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corticosteroid to pregnant women at the risk for premature delivery if delivery did not 
occur in 7-10 days after the initial treatment. This protocol creates an intrauterine 
environment where exposure to synthetic corticosteroids is long lasting.  Interestingly, in 
most of these prenatal glucocorticod therapy protocols the synthetic glucocorticoid 
employed is dexamethasone.  
 By the late 1990’s emerging evidence, particularly from animal studies, have 
suggested that there may be long term consequences on early brain development 
following multiple exposures to sGC (Smith et al.,  2000). These consequences of 
repeated DEX administration were unexpected since it was thought that maternal 
corticosteroids are unavailable to the fetal brain due to CBG and 11β hydroxysteroid 
dehydrogenase (11 β HSD) activities. However it was found that CBG cannot bind DEX 
nor is the latter a good substrate for 11 β HSD (Owen D, 2002). Thus it was finally 
concluded that prenatal exposure of sGC increases the level of glucocorticoid in the fetal 
blood.  Excess GC significantly alters the fetal endocrine environment and interferes with 
the programming of the CNS especially in areas such as the hippocampus which 
ultimately regulate the HPA axis and incoming serotonergic projections involved in 
modulating its activity. 
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SPECIFIC AIMS OF THE STUDY. 
 This study was designed to test the hypothesis that prenatal dexamethasone 
treatment alters 5HT1A receptor function and may be associated with a hyperactive HPA 
axis.  Due to the increase in occurrence of preterm fetal delivery dexamethasone has been 
increasingly used during late gestation (G.C, Liggins; R.N, Howie, 1972). Although the 
use of prenatal dexamethasone therapy has been shown to augment the fetal lung 
development, newer research conducted during the late 1990’s and early 2000 showed 
that prenatal glucocorticoid therapy has long term consequences for fetal brain 
development (G.N, Smith et al. 2000 ; Matthews S.G, 2000) and that it alters the 
hippocampal drive on HPA axis (Shoener et al. 2006; Weinstock, M., 1997). As stated 
previously, studies also suggest that fetal glucocorticoid exposure is part of the 
mechanism by which prenatal stress programs the offspring (Maccari, et al.  2003 & 
Welberg L.A., Seckl J.R, 2001). In fact, the hyperactivity of HPA axis following prenatal 
dexamethasone exposure is believed to be due to changes in negative feedback mediated 
through the corticosteroid receptors especially in the MR/GR ratio. In addition, although 
ADX studies and neuronal lesions have shown that circulating corticosteroids exert a 
negative regulation on the serotonergic system (Curzon et.al 1972 and Van Loon, G.R 
et.al 1981),  activity of the serotonergic system is also mediated through the different 
types of serotonin receptors in the hippocampus and higher cortical centers. 5HT1A and 
5HT2A receptors by virtue of their capability to acts as anxiolytic and anxiogenic 
mediators have been a focal point for research (Graeff et al. 1993; Ramboz et al.1998). 
Studies  show that the expression of the 5HT1A receptor is under tonic inhibition by 
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adrenal steroids in the hippocampus and elsewhere in the brain where mineralocorticoid 
receptors are expressed (Lopez et al. 1998) and that glucocorticoid action on serotonergic 
function may be involved in limbic system dysfunction. For example, a deficiency in 
brain serotonergic activity has been proposed to increase vulnerablitiy to major 
depression (Asberg et al. 1986). It is possible that a diminished availability of  5-HT 
precursors such as L-tryptophan, impairments  in 5-HT synthesis, release or metabolism, 
and changes in 5-HT receptor function could underly this affect disorder.  
In summary this study will attempt to answer the following questions: 1) Does 
prenatal dexamethasone treatment alter the binding affinity of 5HT1A receptors in the 
hippocampus  2) Is there a change in 5T1A receptor density in this region of the brain 
following the treatment 3) Does prenatal dexamethasone treatment alter intracellular 
signalling  from these receptors upon stimulation? 
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MATERIALS AND METHODS 
 
EXPERIMENTAL ANIMALS AND DEX TREATMENT 
 Pregnant female Sprague-Dawley dams were obtained on the 9th day of gestation 
from Hilltop Laboratories.  Since the fetal HPA axis develops only after gestation day 
(GD) 12 -13, the stress due to transportation of the dams is less likely to affect the 
former.  All animals were maintained on standard rat chow providing 3.85kcal/g (dry 
weight) and at conditions of controlled lighting (0600-1800 hours) and temperature 
(23°C). These rats were given a week of acclimatization before treatment. They were 
randomly divided into two groups namely the control and dex. The treatments began on 
GD 14 with the dex group receiving daily injections (sc) of dexamethasone @ 
150µg/kg/day: Sigma St.Louis, MO) and the control group receiving vehicle (0.9% saline 
+ 0.4% ethanol) until GD 19. Data from earlier studies prove that DEX treatment 
@200µg/kg/day or greater resulted in significant growth retardation and lethality in 
offspring. Offspring weighed at birth were distributed in such a way that each dam nursed 
10 pups, which ensured that the pups were neither overfed nor underfed. The offspring 
were sexed and weaned on postnatal day 21 and females were terminated. The males 
were then distributed at the rate of 2/cage according to litter preserving the treatment 
groups. The offspring were also fed the same standard rat chow (3.85kcal/g). At 90 days 
of age the control and the dex animals were terminated. All animals were asphyxiated 
with CO2 in a pre-charged chamber and terminated by guillotine. Terminations were 
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staggered between the two groups to prevent variability in resting periods. Immediately 
followed by each termination, the hypothalamus and the hippocampus were excised and 
stored in eppendorf tubes at -80ºC. Additional trunk blood samples were collected 
immediately upon termination and were centrifuged at 1300 rpm for 5 min at 4ºC. Serum 
aliquots were stored at -80ºC for CORT assay using radioimmunoassay. 
TISSUE GRINDING. 
The hippocampus stored at -80°C was ground into fine suspension using a polytron tissue 
homogenizer in 50mM Tris buffer (at 4°C, pH 7.4).  The tissue homogenate from this 
first round of grinding was then centrifuged using Beckman Coulter centrifuge at 
18000rpm (40000 g) at 4°C for 20 minutes. The resulting tissue pellet was then subjected 
to another round of grinding and centrifugation followed by a final grinding using 20mM 
Tris buffer (at RT, pH7.4). During this round of grinding the volume of the buffer was 
closely monitored to make the final tissue concentration to 2mg/ml (concentration used 
during the radioligand receptor binding assay). A portion of the final homogenate was 
used for the radioligand receptor binding assay and the other was saved at -80ºC for [35S] 
GTPγS incorporation assay. 
 
RADIOLIGAND RECEPTOR BINDING ASSAY  
 The radioligand receptor binding assays are typically used to measure the binding 
affinity of the receptor for its ligand as well as to determine the density of receptors in the 
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tissue used. This assay makes use of a radiolabelled ligand (agonist or an antagonist), 
specific for the receptor in question. Incorporation of any nonspecific binding was 
avoided by using a selective receptor antagonist along with the radiolabelled ligand. 
  In this study the 5HT1A receptor antagonist [H3] MPPF (2'-methoxyphenyl-(N-
2'-pyridinyl)-p-fluoro-benzamidoethyipiperazine) (Perkin Elmer, USA) (specific activity 
of 78.3 Ci/mmol) was used as the radioligand. Serial two fold dilutions of the radioligand 
were made using 20mM Tris buffer (at RT, pH7.4) from 10.56 nM up to 8 dilutions. 
Assay tubes were also labeled from 1 to 8 in triplicates. 250µL of the ligand from each 
dilution was then pipetted into each corresponding triplicate assay tubes. This was 
followed by the distribution of the tissue homogenate into all assay tubes at 500µL per 
tube. To make up the volume to 1 ml per tube another 250 µL of 20mM Tris buffer (at 
RT, pH7.4) was added to each tube. The tubes were then incubated at 25°C in a water 
bath for one hour. The same set up was followed for estimating the nonspecific binding 
using WAY-100635 (N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl] ethyl]-N-2-
pyridinylcyclohexanecarboxamide maleate salt) (Sigma, St.Loius, MO) at 4μM 
concentration (in 20mM Tris) using another set of 8x3 assay tubes that received same 
respective dilutions of the radioligand, except that instead of adding the final 250μL of 
the 20mM Tris buffer for volume make up, 250μL of 4μM WAY-100635 was used 
which was also incubated at 25°C in a water bath for one hour. 
 Also to another set of 8x2 scintillations vials, 500μL of the respective radioligand 
dilutions were added to get the total count of radioactivity added to each assay tube. 
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Cell Harvesting and Scintillation Counting 
 The reaction between cell membranes and the radiolabeled ligand was terminated 
by rapid filtration through Whatman GF/B glass fiber filter soaked in polyethylene glycol 
using a 24 tube Brandel cell harvester. The filter with the harvested radiolabelled cell 
membrane was then allowed to dry for an hour. The dried filter was cut out into circles 
corresponding to the number of the respective assay tubes which were then distributed 
into same numbered scintillation vials and 3ml of scintillation flour was added into each 
vial. Scintillation vials were left undisturbed for about 24 hours for proper integration of 
the flour with the filter after which they were taken into a liquid scintillation counter for 
reading the residual radioactivity in cpms.  The liquid scintillation counter was 
programmed to read only 3 H channel for a preset time of 1 minute per sample. Data was 
then analyzed using the non linear curve fitting program LIGAND (Munson & Rodbard, 
1980). 
 
[35 S]GTPγS INCORPORATION ASSAY  
 The homogenate saved after tissue grinding was used to study the intracellular 
signalling from the 5HT1A receptors upon activation by a ligand (agonist). This study 
made use of the fact that the 5HT1A receptors are G-protein coupled receptors.  
Three fold serial dilutions of the 5HT1A receptor agonist 8-OH-DPAT(8-
hydroxy-2-(di-n-propylamino) tetralin) (Sigma, St.Loius, MO) were prepared in 50mM 
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Tris (@RT, pH 7.4) starting at 10 μM up to 6 dilutions. The 4X GTP buffer was made by 
mixing 400mM NaCl (Sigma, St.Loius. MO), 0.8mM EGTA (Sigma, St.Loius. MO)  and 
12mM MgSO4 (Sigma, St.Louis. MO) in 50mM Tris buffer (pH 7.4, R.T). 120mM GDP 
buffer was made by dissolving GDP (Sigma, St.Loius. MO) in 4X GTP buffer. After 
calculating the radioactivity using the radioactivity decay calculator a 400pM stock of the 
[35 S] GTPγS (specific activity of 1250Ci/mmol) was made in 120mM GDP buffer. 
Unlabeled GTPγS (40μM; Sigma, St.Loius. MO) was also prepared in 50mM Tris buffer 
(Sigma, St.Loius. MO) (pH 7.4, R.T). 
The assay set up consist of triplicates of 6 assay tubes, another of basal and yet 
another of nonspecific. 250μL of the drug (8-OH-DPAT) from each dilution were 
pipetted into the 6 triplicates of corresponding assay tubes. To the basal tubes 250μL of 
50mM Tris buffer (pH 7.4, R.T) was added. To the nonspecific 250μL of the 40μM 
unlabeled GTPγS was added. All the tubes received 250μL of [35 S] GTPγS and followed 
by the addition of 500μL of the tissue homogenate at 1mg/mL.  
Cell Harvesting and Scintillation Counting 
All the tubes were incubated exactly for 45 minutes at 30°C and the reaction was 
terminated as before by rapid filtration onto a Whatman GF/B glass fiber filter as before 
using the cell harvester. Filter with the harvested radiolabelled cell membrane was then 
allowed to dry for an hour. The dried filter was cut out into circles corresponding to the 
number of the respective assay tubes which were then distributed into same numbered 
scintillation vials and 3ml of scintillation flour was added into each vial. Scintillation 
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vials were left undisturbed for about 24 hours for proper integration of the flour with the 
filter after which they were taken into a liquid scintillation counter for reading the 
residual radioactivity in cpms. The liquid scintillation counter was programmed to read 
only 35 S channels for a preset time of 1 minute per sample. The results obtained were 
used to calculate stimulation maximum (E max) and EC50 values of the ligand for the 
receptor, from linear regression plots with the reciprocal of ligand (8-OH-DPAT) 
concentrations on the X axis and reciprocal of percentage stimulation on the Y axis. 
This study was conducted in accordance with the National Institute of Health 
Guide for Care and Use of Laboratory Animals, and the protocols have been approved 
by the Animal Care and Use Committee of Bucknell University 
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RESULTS 
 
Body Weight and Energy Intake  
Dams that had been treated with 150µg/kg DEX daily from GD14-19 had offspring with 
significantly reduced birth weights (Fig.1, Table.1; 6.79 ± 0.18 g, n= 5 for dex group; 
versus 8.00 ± 0.21 g, n=4 for control; P=0.004), which is in agreement with previous 
studies (Keller-Wood & Dallman, 1984; Kinnunen et al., 2003; Shoener et al., 2006). In 
addition prenatal DEX exposed groups also continued to show reduced body weight at 
weaning (Fig 1., Table.1; 27.76 ± 0.34 g, n=5 for dex group; versus 34.32 ± 1.5 g, n=4 
for control; P <0.0005), puberty (Fig. 2., Table.1; 337.7 ± 3.4 g, n=5 for dex group; 
versus 374.4 ± 5.8 g, n=4 for control; P<0.0005) and on the day of sacrifice (Fig 2., 
Table.1; 521.2 ± 5.8 g, n=5 for dex group; versus 569.0 ± 10 g, n=4 for control; P 
<0.0005). These results suggest a permanent metabolic disturbance in the treated animals 
which was supported by the significantly reduced daily energy intake in these animals 
(Fig. 3. Table.1; 184.9 ± 0.61 kcal/day, n=5 for dex group; versus 192.3 ± 0.76 kcal/day, 
n=4 for control; P<0.0005) 
 
Binding Affinity and Receptor Density of Hippocampal 5-HT1A Receptors 
 In order to study the binding affinity and receptor density of hippocampal 5HT1A 
receptors, radio-ligand receptor binding assays were done as described in the materials 
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and methods section. We found that prenatal dex exposure significantly increased the 
number of 5HT1A receptors (Bmax) in the rat hippocampus by 35% (Fig.4., Table.2; 
6.1379 ± 0.355 g, n=5 for dex group; versus 4.5868 ± 0.298 g, n=4 for control, P=0.002). 
However these changes in receptor density occurred with no significant change in 
5HT1A receptor affinity (Kd) (Fig 5). The Kd value for the dex group was 2.53 ± 0.143 
nM versus 2.298 ± 0.156 nM for control group (P=0.292). A Scatchard plot of the 
specific binding is given in Fig.6. This figure illustrates that the regression lines are 
parallel, indicating that there is no change in receptor affinity, whereas increased 
intercept on the horizontal axis indicates a large increase in Bmax of 5HT1A receptors in 
treatment group (dex animals). 
 
 G protein activation of 5HT1A Receptors. 
The differences in the intracellular signalling of 5HT1A receptors were measured 
in terms of [35 S] GTPγS incorporation and the Emax and EC50 values were calculated. The 
results showed that there is no significant difference in ligand mediated maximum 
stimulation (Emax) of hippocampal 5HT1A receptors between control and dex group 
(Fig.7., Table.2; 35.91 ± 2.0 % for dex group; versus 30.83 ± 1.8 % for control, 
P=0.069).  However the EC50 values of 5HT1A receptors in dex group was higher than in 
the control by around 51% (Fig.8., Table.2; 0.2258 ± 0.02 µM for dex group; versus 
0.1095 ± 0.0155 µM for control, P=0.002) indicating that the former required a higher 
concentration of the ligand (8-OH-DPAT) for saturating 50% of its hippocampal 5-HT1A 
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receptors compared to the control.  A double reciprocal plot is given in Fig 9. This figure 
illustrates that there is no change in E max values between control and dex animals, 
whereas a higher intercept for the dex compared to control on the X-axis indicates a 
larger EC50 value for dex exposed animals.  
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DISCUSSION 
 
 In the present study we demonstrate, for the first time, that prenatal exposure to 
dexamethasone alters the hippocampal 5HT1A receptor number and the efficiency of 
ligand mediated G-protein activation in adult male rats.  Earlier studies from our lab and 
others show that rats exposed to excess levels of maternal and synthetic glucocorticoid in 
utero experience changes in hippocampal MR and GR expression that leads to 
destabilization of HPA axis regulation (Takahashi et al., 1991; Henry et al., 1994; 
Shoener et al.,  2006). Additional studies have also shown that HPA axis activity is 
modulated by serotonergic function (Klaassen et al., 2002) .  
 The relationship between corticosteroids and the serotonergic system was first 
reported following autoradiographic studies which identified increased 5HT1A receptor 
binding in the rat hippocampal formation one week after bilateral adrenalectomy (Biegon 
et al., 1985). This report emphasized the responsiveness of the 5HT1A  receptor to 
CORT. In addition, several investigators have reported increases in 5HT1A receptor 
binding and gene expression in adrenalectomised (ADX) rats demonstrating that these 
receptors are under tonic inhibition from corticosterone. Cumulatively, these studies 
emphasize the relationship between the serotonergic system and corticosteroids, however, 
it is important to note that these findings were in response to only postnatal alterations in 
the level of coritcosteroids. To our knowledge only a few studies have investigated the 
effects of prenatal glucocorticoid exposure on the serotonergic sysytem. Since 
25 
 
 
glucocorticoids and serotonergic function interact to control hippocampal negative 
feedback regulation of HPA axis activity, we investigated the effect of prenatal DEX (a 
synthetic glucocorticoid) on 5HT1A function by measuring receptor number, binding 
affinity and ligand-mediated receptor  G- protein activation. The key findings of our 
study are that: (1) prenatal DEX administration increases the total 5HT1A receptor 
number in the hippocampus (2) the functionality of these receptors is reduced in 
experimental animals as evidenced by the increased EC50 values compared to controls 
and (3) DEX rats consistently showed an attenuated growth rate and energy intake 
throughout the study. This latter finding is consistent with other reports, one of which 
followed the same paradigm of in utero DEX-exposure (Shoener et al., 2006) and the 
other that adopted a gestational stress model (Baker, et al., 2009). However, our data 
showing increased 5HT1A binding concurrent with a reduction in ligand-mediated G-
protein activation is novel and warrants further investigation. 
 The 5HT1A receptors are expressed in two distinct populations in the brain: as 
somatodendritic autoreceptors on serotonin containing neurons of the raphe nuclei and as 
a heteroreceptor on the postsynaptic membrane of non-serotonin containing neurons in 
the cerebral cortex and limbic systems. In the raphe nuclei, locally released 5HT acts on 
autoreceptors to inhibit neuronal firing (Wang & Aghajanian, 1977; Celada  et al., 2001) 
and reduces 5HT release in all projection targets. 5HT1A heteroreceptors, which are 
more concentrated in the cortex and hippocampus, are also inhibitory. For example, the 
bindng of [3H]-8-OH-DPAT, a 5HT1A receptor agonist, was reduced in both frontal 
cortex and hippocampus following chronic treatment with an antidepressant, a 5HT 
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reuptake inhibitor, imipramine (Mizuta & Segawa, 1989), presumably due to the down 
regulation of postsynaptic 5HT1A receptor population owing to the  increased 
concentrations of 5HT available for binding at the synaptic cleft. This suggests that 
5HT1A heteroreceptors are responsive to varying levels of 5HT release and together, 
these data underscore the integrated actions of both 5HT autoreceptors and 
heteroreceptors in serotonergic signalling.  Recent studies (Slotkin et al., 2006)  reported 
an increase in 5HT1A receptor binding in the cortex in response to prenatal doses of 
0.05mg Dex/kg to 0.8mg/kg from GD 17-19. Our data are in line with these results since 
we found a significant increase in hippocampal 5HT1A receptor binding, although our 
protocol involved a 0.15 mg DEX/kg from GD 14-19. Together these data are mutually 
supportive since the functions of the 5HT1A receptor in these brain regions are 
overlapping. 
 When considering the interactions between glucocorticoid exposure and 
serotonergic function, it is important to recognize that CORT action is mediated by two 
types of intracellular receptors, the mineralcorticoid receptor and glucocorticoid receptor. 
While CORT binding to MR is crucial to the tonic activation and regulation of circadian 
driven processes, CORT binding to GR is most influential during the circadian peak. 
Many studies have shown that these receptors act together to regulate the HPA axis rather 
than one of the receptors alone (De Kloet et al., 1986; Gesing, et al., 2001). Interestingly, 
the MR and GR colocalization has been detected only in the hippocampus and frontal 
cortex making them the most studied brain regions in relation to the HPA axis and its 
negative feedback mechanisms. In addition to its MR/GR activities, CORT selectively 
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down regulates 5HT1A receptor mRNA expression in hippocampal areas, but not in 
dorsal raphe nulei (Neumaier et al., 2000), presumably due to a higher CORT receptor 
density in post compared to presynaptic sites (Reul & De Kloet, 1985). However this 
finding by Neumaier et al cannot be used to predict the changes in hippocampal 5HT1A 
receptors following prenatal exposure to glucocoticoids, especially dexamethasone. This 
is because the timing of brain growth spurt is critical and  during this period, brain 
development is very susceptible to external manipulation. Therefore, manipulation of the 
fetal environment during late gestation will impact on later stages of  brain and HPA 
development. So findings from our study emphasize the impact of prenatal programming 
of the brain in response to synthetic glucocorticoid exposure. Our study shows that 
following prenatal DEX exposure there is an increase in the number of hippocampal 
5HT1A receptors  coupled to a decrease in their function. Thus  we state that, in addition 
to the earlier findings about the decrease in GR and MR receptors following prenatal 
exposure to dexamethasone, there is an overall decrease in function of hippocampal 
5HT1A receptors.   
 However, the increase in 5HT1A receptors in response to CORT found in other 
studies must be clarified in the context of this receptor’s function. For example, it has 
been previously shown that 5HT1A receptor knockout mice showed increased anxiety-
like behavior, in three paradigms: open field, EPM, and novelty suppressed feeding 
(Ramboz et al., 1998; Gross  et al., 2000), however, these mice could be “rescued” if 
their 5HT1A receptor expression was restored during adult stage.  Thus, when 5HT1A 
function is lost in these knock-out mice, a propensity for anxiety-related behaviors 
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ensues. It could be hypothesized that this serotonin receptor, in part, mediates 
emotionality which is associated with changes in HPA axis activity. A previous study 
from our lab (Shoener et al.,  2006) showed that prenatal exposure to DEX alters 
hippocampal drive which resulted in HPA axis hyperactivity in DEX-exposed animals. 
After considering the results from both of our studies it could be assumed that the 
hyperactivity of HPA axis observed in our prenatally DEX exposed rats could be, in part, 
due to a decrease in the 5HT1A receptor functions. Although the DEX exposed animals 
in our study exhibit an increase in 5HT1A receptor density, the concomitant increase in 
the EC50 value of these receptors suggests that the dose of agonist required to activate the 
receptors and induce GTP incorporation was significantly higher. These findings support 
the hypothesis that 5HT1A receptor function has been impaired by exposure to prenatal 
DEX. 
 Although serotonin release is a key component of serotonergic function, a study 
by Slotkin et al (2006) found that alterations in presynaptic serotonin level and turnover 
are not the sole driving force behind the effects of DEX on 5HT1A receptors since 
upregulation was seen regardless of whether serotonin levels were increased, decreased 
or remain unchanged. In fact, increases in 5HT1A receptors in the face of a rise in 
presynaptic serotonin release appears particularly puzzling, since ordinarily one would 
expect to see compensatory downregulation of the postsynaptic receptors. This 
disconnection however provides important clues as to potential mechanisms underlying 
the effects of DEX on serotonergic function. For example, a similar pattern of 
postsynaptic receptor upregulation concomitant with higher presynaptic activity has also 
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been reported with neuroteratogens unrelated to DEX and typically reflects loss of 
postreceptor-signalling capabilities (Shahak et al., 2003). In such a situation the failure of 
synaptic signals to activate postsynaptic 5HT1A receptor signalling might lead to both an 
increase in presynaptic 5HT release due to reduced effectiveness of 5HT1A autoreceptors 
as well as an upregulation of 5HT1A heteroreceptors in an unsuccessful attempt to 
compensate for the underlying deficiency. In light of these observations, the increase in 
hippocampal 5HT1A receptor number in DEX animals could be an  unsuccesful attempt 
to compensate for less functional receptors and loss of signal transduction as indicated by 
the [35S]GTPγS incorporation assay. The role of 5HT1A autoreceptors and 
heteroreceptors on anxiety and depression are quite controversial. However, a 
considerable body of evidence suggest that these receptors are anxiolytic. For example, 
heteroreceptors appear to play an important role in effects of drugs such as SSRI, which 
are used as antidepressants. In particular, experiments consisting of the selective regional 
rescue of 5HT1A receptors in 5HT1A knockout mice clearly showed that postsynaptic 
5HT1A heteroreceptors in hippocampus are required for the anti-immobility effect of 
SSRI treatment in animals subjected to the tail suspension test (Overstreet et al., 2003):  a 
finding which supports the anxiolytic role of this subset population of 5HT1A receptors. 
Activation of both receptor populations results in membrane hyperpolarization and 
decreased neuronal excitability. For instance activation of 5HT1A autoreceptor by 5HT 
will result in an inhibitory negative feedback on the 5HT producing neurons in the raphe 
nuclei by decreasing the neuronal excitability . This reduction in excitability would then 
result in decreased 5HT output into the synaptic cleft and a resulting  decrease in 5HT 
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binding and activation of  postsynaptic 5HT1A receptors which would in turn reduce 
their  hyperpolarizing effects. Our findings are in partial accordance with this account and 
in addition, recent findings show that ADX (no circulating CORT) diminishes the affinity 
of 5HT1A receptors in the dorsal raphe nuclei (autoreceptors) and CORT increases the 
affinity for 5HT (Bellido et al., 2004). Thus the increase in CORT in the cited study 
(Bellido et al., 2004)  results in decreased firing of the presynaptic serotonergic neurons 
in the dorsal raphe nulceus and a consequent decrease in 5HT available for binding to the 
postsynaptic receptors including 5HT1A heteroreceptors. This reduction in 5HT1A 
receptor activity results in putative anxiogenesis. Our data agrees with these findings 
since a significant decrease in the functionality of 5HT1A heteroreceptors was measured 
following prenatal exposure to DEX.   
  It is likely that the prenatal exposure to DEX in our study, in part, results in a 
perturbation of 5HT1A receptor function and provides the ground for anxiogenic 
outcomes.  This interpretation is further supported by current studies in our lab conducted 
by Joseph Donohue (unpublished). He has shown that although there is no obvious 
differences between control and Dex-exposed adult offspring under basal conditions, a 
brief exposure to stress results in a significant increase in anxiety-like behavior in the 
elevated plus maze (P < 0.03) and a significant increase in circulating CORT (P = 0.003). 
  A vast body of evidence suggests that actions of  5HT mediated through 
the 5HT1A receptors in the dentate gyrus may stimulate the production of neurons in the 
same region. In contrast to neurons in other brain regions the granule cell layer of the 
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dentate gyrus enjoys an extended  period of development from gestation and continuing 
into adulthood, with a continual migration of granule cell precursors into the 
hippocampus from the lateral ventricles (Altman & Bayer, 1990; Rickmann et al., 1987). 
Moreover,  the role of hippocampal formation in learning and memory has been 
recognized for decades (Squire & Zola, 1996) and many abberations in the hippocampus 
have been associated with alterations in these attributes. It is possible that defects in 
learning and memory exhibited by mice and rats following prenatal glucocorticoid 
therapy (Emgard et al., 2007; Noorlander et al., 2007) could be further illuminated by our 
findings which support the hypothesis that prenatal dexamethasone induced hippocampal 
5HT1A dysfunction may result in suppression of hippocampal neurogenesis and 
subsequent deficits in memory and learning. 
Future Directions: 
There is growing evidence that 5HT1A receptors together with 5HT2A receptors 
are responsible for the regulation HPA axis. Extensive studies have shown that 5HT1A 
receptor agonists have effects similar to 5HT2A receptor antagonists in a variety of 
systems (Darmani et al., 1990; Meltzer & Maes, 1995). Additional evidence about the 
difference in function of these two classes of 5HT receptors comes from the observation 
that administration of CORT or ACTH alters the numbers of both 5HT1A and 5HT2A 
receptors quite substantially in opposite directions. In the light of all these observations 
from previous studies, our lab is currently preparing to explore the effects on 5HT2A 
receptors in the hippocampus as well as cortical tissue following prenatal DEX exposure. 
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 The hippocampus is divided into two functionally different regions, the dorsal and 
ventral hippocampus. Whereas the ventral part of the hippocampus is primarily 
implicated in emotional processing, the dorsal part is mainly linked to learning and 
memory (Bannerman, et al., 2004). Since our study did not measure the effect on 5HT1A 
receptors separately on the ventral and dorsal hippocampus, it would be interesting to 
investigate the effect of prenatal DEX exposure on these receptors in these individual 
regions. 
 As mentioned earlier Bellido et al (2004) has reported an increase in 5HT1A 
autoreceptors in response to corticosterone. Since neuronal firing mediated by serotonin 
will depend upon the action of the entire 5HT1A receptor subfamily, comprising both 
autoreceptors and heteroreceptors, the hyperactivity of HPA axis observed in a previous 
study by Shoener  et al (2006) cannot be explained with the changes in the heteroreceptor 
population alone. A more comprehensive picture could be drawn if the effect on 5HT1A 
autoreceptors could be studied following the same stress paradigm. 
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Table 1. Effects on weight at birth, weaning, puberty and on the day of sacrifice 
following prenatal exposure to DEX 
 
Group Birth 
weight(g) 
Weaning 
weight (g) 
Weight at 
puberty (g) 
Sacrifice 
weight (g) 
Energy 
intake, 
(kcal/day) 
Control 8.003±0.21 34.32±1.5 374.4±5.8 569.0±10 192.3±0.76 
Dex-exposed 6.791±0.18* 27.76±0.34* 337.7±3.4* 521.2±5.8* 184.9±0.61*
 P =0.004 P < 0.0005 P < 0.0005 P < 0.0005 P < 0.0005 
 
Values are means ± S.E. P=0.004, P<0.0005 indicate significant difference between dexamethasone 
(DEX)- exposed animals compared with controls using 1-way ANOVA for weights. 
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Figure.1. Difference in the average weight at birth and weaning of dex exposed and control animals. 
The birth weight of dex animals was significantly lower than control by 15%; P= 0.004. The weaning 
weight of dex animals was significantly lower than control by 19%; P<0.0005. 
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Figure.2. Difference in the average weight at puberty and sacrifice of dex exposed and control 
animals. The pubertal weight of dex animals was significantly lower than control by 10% (P<0.0005). 
The terminal weight of dex animals was significantly lower than control by 8.5% (P<0.0005). 
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Figure.3. Difference in the average daily energy intake of dex exposed and control animals. The 
energy intake of dex animals was significantly lower than control by 3.8% (P<0.0005) 
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Table 2. Values for Dissociation constant, Binding Maximum, Stimulation Maximum, 
and Effective concentration50 values (EC50) for hippocampal 5HT-1A receptor in Control 
and Dex-exposed animals  
 
 
Using the radioligand receptor assay, no significant differences were found in the binding affinity, Kd, 
(P=0.292), whereas a significant increase in binding maximum, Bmax, was observed in the Dex-
exposed animals (P= 0.002). In addition, no significant difference in maximum stimulation (Emax) of 
5HT1A receptor and GTPγS incorporation was detected (P=0.069). However, the effective 
concentration of 5HT1A receptor agonist required for maximal stimulation was almost two-fold 
higher in the Dex-exposed group (P= 0.002) Values are mean ± S.E.M. 
 
 
 
 
 
 
 
 
 
 
 
Group  Kd (nM) Bmax(fmol/mg 
tissue) 
Percent 
Stimulation 
Max (Emax) 
EC50  (μM)  
Control  2.298±0.156 4.587±0.298 30.83±1.8 0.119±0.0155  
Dex-exposed  2.531±0.143 6.138±0.355* 35.91±2.0 0.226±0.02*  
 P = 0.292 P = 0.002 P = 0.069 P =0.002  
50 
 
 
 
 
 
 
 
Figure.4. Difference in the Bmax values of control and dex exposed animals. Increased Bmax in dex 
exposed animals indicate an increase in 5HT1A receptor density. Dex animals showed a receptor 
density 35% higher than the control animals; P=0.002. 
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Figure.5. This graph illustrates the values for the dissociation constant (Kd) which reflect the binding 
affinity of the 5HT1A receptor for its ligand ([H3] MPPF). No significant difference in the affinity was 
found following prenatal dexamethasone exposure; P=0.292. 
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Figure 6. Scatchard analysis of [3 H] MPPF binding to rat hippocampal 5HT-1A receptors in Control 
and Dex animals. Each regression line is based on one pair of representative animals. 
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Figure.7. This graph shows the values of Stimulation max (Emax) which is a measure of the 
maximum stimulation of [35 S] GTPγS incorporation assay following ligand (8-OH-DPAT) mediated 
activation of 5HT1A receptor. No significant difference in the maximum stimulation was found owing 
to prenatal dexamethasone exposure; P=0.069. 
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Figure.8. Effects of prenatal exposure of dexamethasone on the EC50 value of 5HT1A receptor. The 
EC50 values were determined by measuring the extent of incorporation of GTPγS following ligand (8-
OH-DPAT)-mediated stimulation of the 5HT1A receptor). The dex animals showed a 51% increased 
EC50 value compared to controls; P=0.002. 
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Figure.9. Double reciprocal plots illustrate stimulation of the 5HT1A receptor at increasing agonist 
concentrations, 8-OH-DPAT, between dex exposed and control group. Each regression line is from 
one representative animal.  
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